| 产品描述: | TD-165 是基于 PROTAC 技术的 CRBN 降解剂。 TD-165 包括一个 CRBN 配体结合基团,一个 linker 和一个 VHL 结合基团。 |
| 靶点: |
Cereblon 20.4 nM (DC50);LigandforE3Ligase |
| 体外研究: |
TD-165 (0-100 nM; 24 hours) shows 50% degradation concentration (DC50) and maximum degradation (Dmax) value of 20.4 nM and 99.6%, respectively. TD-165 (0.1-10 μM; 24 hours) leads to a concentration-dependent decrease in the level of CRBN proteins in HEK293T cells. |
| 参考文献: |
1. Kim K, et al. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera.Sci Rep. 2019 Dec 23;9(1):19654. |
| 溶解性: |
Souble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.149 ml |
5.747 ml |
11.493 ml |
| 5 mM |
0.23 ml |
1.149 ml |
2.299 ml |
| 10 mM |
0.115 ml |
0.575 ml |
1.149 ml |
| 50 mM |
0.023 ml |
0.115 ml |
0.23 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |